Cargando…

Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers

For patients with locally advanced rectal cancer (LARC) treated with preoperation chemoradiation (pCRT), identifying differentially expressed (DE) genes between non-responders and responders is a common approach for investigating mechanisms of chemoradiation resistance. However, some of such DE gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, You, Cheng, Jun, Ao, Lu, Li, Xiangyu, Guan, Qingzhou, Zhang, Juan, Yan, Haidan, Cai, Hao, Gao, Qiao, Jiang, Weizhong, Guo, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109405/ https://www.ncbi.nlm.nih.gov/pubmed/27845363 http://dx.doi.org/10.1038/srep36935

Ejemplares similares

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
por: Conde-Muíño, Raquel, et al.
Publicado: (2015)

A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation
por: Xue, Zhengfa, et al.
Publicado: (2021)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety
por: Peponi, Evangelia, et al.
Publicado: (2015)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation
por: Wan, Juefeng, et al.
Publicado: (2015)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
por: Ott, Oliver J., et al.
Publicado: (2021)

Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer
por: Popiţa, Anca-Raluca, et al.
Publicado: (2023)

Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer
por: Jensen, Garrett L., et al.
Publicado: (2023)

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
por: Cai, Hao, et al.
Publicado: (2015)

Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues
por: Tong, Mengsha, et al.
Publicado: (2015)

Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments
por: Ao, Lu, et al.
Publicado: (2015)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms
por: Guan, Qingzhou, et al.
Publicado: (2016)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer
por: Seo, Incheol, et al.
Publicado: (2021)

3.0 T MRI IVIM-DWI for predicting the efficacy of neoadjuvant chemoradiation for locally advanced rectal cancer
por: Hu, Hongbo, et al.
Publicado: (2020)

The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer
por: Palma, Pablo, et al.
Publicado: (2010)

Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer
por: Jwa, E, et al.
Publicado: (2014)

Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules
por: Park, Shin-Hyung, et al.
Publicado: (2016)

The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation
por: Dudani, Shaan, et al.
Publicado: (2021)

Predicting outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiation with CT-based radiomics
por: Wang, Fuqiang, et al.
Publicado: (2022)

T2 relaxation time for the early prediction of treatment response to chemoradiation in locally advanced rectal cancer
por: Ge, Yuxi, et al.
Publicado: (2022)

Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
por: Fei, Fei, et al.
Publicado: (2019)

Microbial Characteristics of Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiation Therapy According to Pathologic Response
por: Fan, Qilin, et al.
Publicado: (2021)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: A Comparison of Bolus 5-Fluorouracil/Leucovorin and Capecitabine
por: Yoney, Adnan, et al.
Publicado: (2014)

Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer
por: Han, Kyung Su, et al.
Publicado: (2016)

Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
por: Chen, Min, et al.
Publicado: (2019)

Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities
por: Lim, Stephanie Hui-Su, et al.
Publicado: (2019)

Tumor Microenvironment before and after Chemoradiation in Locally Advanced Rectal Cancer: Beyond PD-L1
por: Tayshetye, Pritam, et al.
Publicado: (2022)

Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?
por: Lutsyk, Myroslav, et al.
Publicado: (2023)

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2018)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
por: Habermehl, Daniel, et al.
Publicado: (2012)

Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer
por: Chau, I, et al.
Publicado: (2003)

Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
por: Dickman, Ram, et al.
Publicado: (2013)

Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2018)

Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer
por: Raldow, Ann C., et al.
Publicado: (2019)

A qualitative transcriptional signature for the early diagnosis of colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2019)

Change of telomerase activity in rectal cancer with chemoradiation therapy.
por: Kim, H. R., et al.
Publicado: (2000)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vt3e7t491omgt2k1uh8ha7483c